121 related articles for article (PubMed ID: 35351630)
1. Polyethylene Glycol Drug-Eluting Embolic Microspheres Loaded with Doxorubicin for the Treatment of Hepatocellular Carcinoma: Feasibility, Safety, and Pharmacokinetic Study.
Malagari K; Denys A; Burrel M; Reig M; Brunet M; Duran R; Kiakidis T; Moschouris H; Sanduzzi-Zamparelli M; Bruix J
J Vasc Interv Radiol; 2022 Jul; 33(7):752-761. PubMed ID: 35351630
[TBL] [Abstract][Full Text] [Related]
2. Transarterial Chemoembolization Using 100-μm Drug-Eluting Microspheres in Patients with Hepatocellular Carcinoma: A Prospective Study and Midterm Follow-up.
Ou HY; Wu YN; Yu CY; Chen CL; Hsu HW; Weng CC; Leung-Chit Tsang L; Huang TL; Tong YS; Lim WX; Cheng YF
J Vasc Interv Radiol; 2020 Nov; 31(11):1784-1791. PubMed ID: 33023805
[TBL] [Abstract][Full Text] [Related]
3. Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards.
Lucatelli P; Argirò R; De Rubeis G; Rocco B; Corradini SG; Corona M; Nardis PG; Saba L; Mennini G; Fiorentino F; Corsi A; Catalano C; Bezzi M
J Vasc Interv Radiol; 2019 Mar; 30(3):305-313. PubMed ID: 30713031
[TBL] [Abstract][Full Text] [Related]
4. Chemoembolization Adopting Polyethylene Glycol Drug-Eluting Embolics Loaded With Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Aliberti C; Carandina R; Sarti D; Mulazzani L; Pizzirani E; Guadagni S; Fiorentini G
AJR Am J Roentgenol; 2017 Aug; 209(2):430-434. PubMed ID: 28537756
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
6. Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
Brown KT; Do RK; Gonen M; Covey AM; Getrajdman GI; Sofocleous CT; Jarnagin WR; D'Angelica MI; Allen PJ; Erinjeri JP; Brody LA; O'Neill GP; Johnson KN; Garcia AR; Beattie C; Zhao B; Solomon SB; Schwartz LH; DeMatteo R; Abou-Alfa GK
J Clin Oncol; 2016 Jun; 34(17):2046-53. PubMed ID: 26834067
[TBL] [Abstract][Full Text] [Related]
7. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.
Reyes DK; Vossen JA; Kamel IR; Azad NS; Wahlin TA; Torbenson MS; Choti MA; Geschwind JF
Cancer J; 2009; 15(6):526-32. PubMed ID: 20010173
[TBL] [Abstract][Full Text] [Related]
8. The effect of doxorubicin loading on response and toxicity with drug-eluting embolization in resectable hepatoma: a dose escalation study.
Klass D; Owen D; Buczkowski A; Chung SW; Scudamore CH; Weiss AA; Yoshida EM; Ford JA; Ho S; Liu DM
Anticancer Res; 2014 Jul; 34(7):3597-606. PubMed ID: 24982375
[TBL] [Abstract][Full Text] [Related]
9. Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres.
Albrecht KC; Aschenbach R; Diamantis I; Eckardt N; Teichgräber U
J Cancer Res Clin Oncol; 2021 Jan; 147(1):23-32. PubMed ID: 32880029
[TBL] [Abstract][Full Text] [Related]
10. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinoma.
Liu YS; Ou MC; Tsai YS; Lin XZ; Wang CK; Tsai HM; Chuang MT
Korean J Radiol; 2015; 16(1):125-32. PubMed ID: 25598680
[TBL] [Abstract][Full Text] [Related]
12. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
13. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
Varela M; Real MI; Burrel M; Forner A; Sala M; Brunet M; Ayuso C; Castells L; Montañá X; Llovet JM; Bruix J
J Hepatol; 2007 Mar; 46(3):474-81. PubMed ID: 17239480
[TBL] [Abstract][Full Text] [Related]
14. A review discussing the use of polyethylene glycol microspheres in the treatment of hepatocellular carcinoma.
Fiorentini G; Sarti D; Carandina R; Mulazzani L; Mincarelli C; Candelari R; Argirò R; Fiorentini C; Aliberti C
Future Oncol; 2019 Mar; 15(7):695-703. PubMed ID: 30444424
[TBL] [Abstract][Full Text] [Related]
15. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma.
Malagari K; Kiakidis T; Pomoni M; Moschouris H; Emmanouil E; Spiridopoulos T; Sotirchos V; Tandeles S; Koundouras D; Kelekis A; Filippiadis D; Charokopakis A; Bouma E; Chatziioannou A; Dourakis S; Koskinas J; Karampelas T; Tamvakopoulos K; Kelekis N; Kelekis D
Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1379-91. PubMed ID: 27393274
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review.
Martin R; Geller D; Espat J; Kooby D; Sellars M; Goldstein R; Imagawa D; Scoggins C
Hepatogastroenterology; 2012; 59(113):255-60. PubMed ID: 22251546
[TBL] [Abstract][Full Text] [Related]
18. Korean Multicenter Registry of Transcatheter Arterial Chemoembolization with Drug-Eluting Embolic Agents for Nodular Hepatocellular Carcinomas: Six-Month Outcome Analysis.
Lee M; Chung JW; Lee KH; Won JY; Chun HJ; Lee HC; Kim JH; Lee IJ; Hur S; Kim HC; Kim YJ; Kim GM; Joo SM; Oh JS
J Vasc Interv Radiol; 2017 Apr; 28(4):502-512. PubMed ID: 27856136
[TBL] [Abstract][Full Text] [Related]
19. Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 μm. Safety and efficacy study.
Malagari K; Pomoni M; Moschouris H; Kelekis A; Charokopakis A; Bouma E; Spyridopoulos T; Chatziioannou A; Sotirchos V; Karampelas T; Tamvakopoulos C; Filippiadis D; Karagiannis E; Marinis A; Koskinas J; Kelekis DA
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):165-75. PubMed ID: 24263774
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma Supplied by Extrahepatic Collateral Arteries.
Lokken RP; Fidelman N; Kolli KP; Kerlan RK
J Vasc Interv Radiol; 2016 Nov; 27(11):1698-1704. PubMed ID: 27397617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
